Refine Search
(4)
(8)
(20)
(20)

Central Nervous System

The CNS therapeutics market is collectively one of the fastest growing markets within the pharmaceutical industry. The primary factors driving the global CNS therapeutics market include the increasing ageing population and the substantial gap in unmet clinical need for major CNS disorders.

Parkinson's Disease - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2018’, provides an overview of the Parkinson's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for...

Multiple Sclerosis - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2018’, provides an overview of the Multiple Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Multiple...

Neuropathic Pain - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2018’, provides an overview of the Neuropathic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Neuropathic ...

Huntington Disease - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Huntington Disease - Pipeline Review, H1 2018’, provides an overview of the Huntington Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Huntingt...

Dental Pain - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dental Pain - Pipeline Review, H1 2018’, provides an overview of the Dental Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dental Pain, complete ...

Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2018’, provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) pipeline landscape.

The report provides comprehensive in...

Depression - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Depression - Pipeline Review, H2 2018’, provides an overview of the Depression pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Depression, complete wit...

Opium (Opioid) Addiction - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Opium (Opioid) Addiction - Pipeline Review, H2 2018’, provides an overview of the Opium (Opioid) Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Epilepsy - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2018’, provides an overview of the Epilepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with anal...

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2018’, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape.

The report provides comprehensive info...

Nicotine Addiction - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nicotine Addiction - Pipeline Review, H2 2018’, provides an overview of the Nicotine Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nicotine...

Visceral Pain - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H2 2018’, provides an overview of the Visceral Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Visceral Pain, com...

Insomnia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Insomnia - Pipeline Review, H2 2018’, provides an overview of the Insomnia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Insomnia, complete with anal...

Narcolepsy - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Narcolepsy - Pipeline Review, H2 2018’, provides an overview of the Narcolepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Narcolepsy, complete wit...

Binge Eating Disorder - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Binge Eating Disorder - Pipeline Review, H2 2018’, provides an overview of the Binge Eating Disorder pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bi...